Patients with RAAS-inhibiting pharmacotherapy in myocardial infarction, proportion (%) - Target level ≥ 90

Number of patients with myocardial infarction and at least one of the high-risk criteria receiving anti-RAAS therapy, divided by the number of patients with myocardial infarction and at least one high-risk criterion. High-risk criteria include previous heart failure, impaired heart function, pulmonary rattles, diabetes, or high blood pressure. For the key performance indicator, Swedeheart has set a higher target level of 90% and a lower target level of 85%.